Today: 23 January 2026
Subscribe
Browse Category

NASDAQ:REVB News 23 January 2026

Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path

Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path

New York, Jan 23, 2026, 08:55 EST — Premarket Revelation Biosciences shares climbed roughly 2% in premarket Friday, adding to a rollercoaster week for the lightly traded biotech. Investors were reacting to the company’s newest regulatory update. The stock last changed hands near $0.85. This move is crucial as the company aims to consolidate early-stage research into one late-stage trial,…
23 January 2026
·····

Stock Market Today

  • Hudbay Minerals Price Target Update Signals Shifts in Market Sentiment
    January 23, 2026, 2:23 PM EST. Hudbay Minerals (TSX:HBM) has seen a recent price target update, signaling a shift in analyst expectations based on new operational and commodity price data. This update reflects evolving fair value estimates, which serve as reference points rather than fixed targets. Analysts employ various valuation methods like cash flow models and net asset value to reassess the stock's potential. Investors are encouraged to monitor these updates as part of a broader strategy considering risk and portfolio fit. Platforms like Simply Wall St offer tools for tracking Hudbay's valuation narratives, helping investors align market developments with their assumptions on revenue, earnings, and margins. The update underscores changing market sentiment around Hudbay Minerals amid ongoing information flow.
Go toTop